Impact of peroral endoscopic myotomy on the endoscopic pressure study integrated system.

EPSIS POEM achalasia endoscopic diagnosis esophagus

Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 22 04 2024
accepted: 18 06 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 18 7 2024
Statut: aheadofprint

Résumé

The endoscopic pressure study integrated system (EPSIS) is an endoscopic diagnostic system utilized for evaluation of lower esophageal sphincter function. Although previous studies have determined that EPSIS was effective as a tool for the diagnosis of achalasia, it remains uncertain if EPSIS can detect significant changes before and after peroral endoscopic myotomy (POEM), which is the premier treatment for achalasia. This study aimed to evaluate the effectiveness of EPSIS as an objective diagnostic tool for assessing the clinical effect of POEM. We conducted a retrospective analysis of patients who underwent POEM from January 2022 to December 2023. The patients underwent EPSIS preoperatively and 2 months postoperatively. Intragastric pressure (IGP) parameters, including the maximum IGP, IGP difference, and waveform gradient were compared pre- and post-POEM. These parameters also were compared between two groups: the postoperative gastroesophageal reflux disease (GERD) group and the non-GERD group. A total of 50 patients were analyzed. The mean maximum IGP was significantly lower postoperatively than preoperatively (15.0 mmHg vs. 19.8 mmHg, P < 0.001). The mean IGP difference and waveform gradient were also significantly lower postoperatively than preoperatively (8.0 mmHg vs. 12.2 mmHg, P < 0.001; and 0.26 mmHg/s vs. 0.43 mmHg/s, P < 0.001, respectively). The mean postoperative waveform gradient was significantly lower in the GERD group (17 patients, 34%) than in the non-GERD group (33 patients, 66%) (0.207 mmHg vs. 0.291 mmHg, P = 0.034). The results supported the use of EPSIS as an effective diagnostic tool for assessing the effect of POEM.

Identifiants

pubmed: 39021248
doi: 10.1111/den.14882
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Japan Gastroenterological Endoscopy Society.

Références

Inoue H, Shimamura Y, Rodriguez de Santiago E et al. Diagnostic performance of the endoscopic pressure study integrated system (EPSIS): A novel diagnostic tool for gastroesophageal reflux disease. Endoscopy 2019; 51: 759–762.
Nishikawa Y, Inoue H, Shimamura Y et al. Simplified endoscopic pressure study integrated system for the diagnosis of gastroesophageal reflux disease. Dig Endosc 2021; 33: 663–667.
Shimamura Y, Inoue H, Rodriguez de Santiago E et al. Characterization of intragastric pressure waveform in endoscopic pressure study integrated system: Novel diagnostic device for gastroesophageal reflux disease. Dig Endosc 2021; 33: 780–787.
Nishikawa Y, Inoue H, Shimamura Y et al. Endoscopic pressure study integrated system for the diagnosis of achalasia. Dig Endosc 2024; 36: 565–572.
Inoue H, Minami H, Kobayashi Y et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265–271.
Inoue H, Sato H, Ikeda H et al. Per‐oral endoscopic myotomy: A series of 500 patients. J Am Coll Surg 2015; 221: 256–264.
Von Renteln D, Fuchs KH, Fockens P et al. Peroral endoscopic myotomy for the treatment of achalasia: An international prospective multicenter study. Gastroenterology 2013; 145: 309–311.
Shiwaku H, Inoue H, Sato H et al. Peroral endoscopic myotomy for achalasia: A prospective multicenter study in Japan. Gastrointest Endosc 2020; 91: 1037–1044.
Hata Y, Sato H, Shimamura Y et al. Impact of peroral endoscopic myotomy on high‐resolution manometry findings and their association with the procedure's outcomes. Gastrointest Endosc 2023; 97: 673–683.
Eckardt VF. Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am 2001; 11: 281–292.
Yadlapati R, Kahrilas PJ, Fox MR et al. Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0(©). Neurogastroenterol Motil 2021; 33: e14058.
Gyawali CP, Yadlapati R, Fass R et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut 2024; 73: 361–371.
Grimes KL, Bechara R, Shimamura Y, Ikeda H, Inoue H. Gastric myotomy length affects severity but not rate of post‐procedure reflux: 3‐year follow‐up of a prospective randomized controlled trial of double‐scope per‐oral endoscopic myotomy (POEM) for esophageal achalasia. Surg Endosc 2020; 34: 2963–2968.
Grimes KL, Inoue H, Onimaru M et al. Double‐scope per oral endoscopic myotomy (POEM): A prospective randomized controlled trial. Surg Endosc 2016; 30: 1344–1351.
Cotton PB, Eisen GM, Aabakken L et al. A lexicon for endoscopic adverse events: Report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446–454.
Kwiatek MA, Post J, Pandolfino JE, Kahrilas PJ. Transient lower oesophageal sphincter relaxation in achalasia: Everything but LOS relaxation. Neurogastroenterol Motil 2009; 21: 1294‐e123.
Quénéhervé L, Vauquelin B, Berger A, Coron E, Olivier R. Risk factors for clinical failure of peroral endoscopic myotomy in achalasia. Front Med (Lausanne) 2022; 9: 1099533.
McMahon BP, Frøkjaer JB, Kunwald P et al. The functional lumen imaging probe (FLIP) for evaluation of the esophagogastric junction. Am J Physiol Gastrointest Liver Physiol 2007; 292: G377–G384.
Donnan EN, Pandolfino JE. EndoFLIP in the esophagus: Assessing sphincter function, wall stiffness, and motility to guide treatment. Gastroenterol Clin N Am 2020; 49: 427–435.
Su B, Callahan ZM, Novak S, Kuchta K, Ujiki MB. Using impedance planimetry (EndoFLIP) to evaluate myotomy and predict outcomes after surgery for achalasia. J Gastrointest Surg 2020; 24: 964–971.
Jain AS, Carlson DA, Triggs J et al. Esophagogastric junction distensibility on functional lumen imaging probe topography predicts treatment response in achalasia‐anatomy matters! Am J Gastroenterol 2019; 114: 1455–1463.
Amundson JR, Wu H, VanDruff V et al. Esophagogastric junction compliance on impedance planimetry (EndoFLIP™) following peroral endoscopic myotomy (POEM) predicts improvement in postoperative Eckardt score. Surg Endosc 2023; 37: 1493–1500.
Ngamruengphong S, von Rahden BH, Filser J et al. Intraoperative measurement of esophagogastric junction cross‐sectional area by impedance planimetry correlates with clinical outcomes of peroral endoscopic myotomy for achalasia: A multicenter study. Surg Endosc 2016; 30: 2886–2894.
Teitelbaum EN, Soper NJ, Pandolfino JE et al. Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes. Surg Endosc 2015; 29: 522–528.
Fujiyoshi Y, Teshima C. Aberrant placement of functional lumen imaging probe into mediastinum during peroral endoscopic myotomy. VideoGIE 2023; 8: 397–400.
Teh JL, Tham HY, Soh AYS et al. Gastro‐esophageal reflux disease (GERD) after peroral endoscopic myotomy (POEM). Surg Endosc 2022; 36: 3308–3316.
Rassoul Abu‐Nuwar M, Eriksson SE, Sarici IS et al. GERD after peroral endoscopic myotomy: Assessment of incidence and predisposing factors. J Am Coll Surg 2023; 236: 58–70.
Familiari P, Greco S, Gigante G et al. Gastroesophageal reflux disease after peroral endoscopic myotomy: Analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis. Dig Endosc 2016; 28: 33–41.
Shiwaku H, Inoue H, Sasaki T et al. A prospective analysis of GERD after POEM on anterior myotomy. Surg Endosc 2016; 30: 2496–2504.

Auteurs

Yohei Nishikawa (Y)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Haruhiro Inoue (H)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Ippei Tanaka (I)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Shotaro Ito (S)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Daisuke Azuma (D)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Kei Ushikubo (K)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Kazuki Yamamoto (K)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Hiroki Okada (H)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Akiko Toshimori (A)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Mayo Tanabe (M)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Manabu Onimaru (M)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Takayoshi Ito (T)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Noboru Yokoyama (N)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Yuto Shimamura (Y)

Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Classifications MeSH